Overview

At Flora Growth Corp. (Flora), we are building the world’s largest and lowest cost vertically-integrated producer of organic cannabis and pharmaceutical-grade medical products as well as OTC CBD-based consumer products.

You Are Not Investing in An Idea

We are developing a business looking to generate revenue in 2020.

To achieve this objective, we have worked tirelessly and developed a strategy that will allow us to make a great difference and generate revenue in the short term.

 

How are we going to do it?

PRODUCT DEVELOPMENT AND LOW PRODUCTION COST

We will control the largest non-psychoactive organic crop of cannabis in the world. This allows us to produce at an expected cost of US$0.18 per gram. If we were to sell our products at the same average price in the US today, we would have a profit margin of nearly 800% (or around 700% in Canada).

 

KEY ACQUISITIONS, UNIQUE BRANDS

We have signed letters of intent to acquire two companies, Cronomed and Mambe, which will allow us to ensure vertical growth and near-term revenue generation. Flora’s beauty and cosmetics division, “Flora Beauty”, will produce nine different beauty and cosmetic products via a high-end product line called “Mind” and a mass-market product line called “Elements” using Flora’s own organic CBD oil.
 

 

 

GLOBALLY SIGNIFICANT WITH HIGH QUALITY PRODUCTS

We expect to supply the worldwide pharmaceutical, cosmetic and food and beverage industries with the highest-quality CBD oils and derivatives in the market.